Drug reference
Malathion
Cholinesterase Inhibitor · Parasiticide
Cholinesterase InhibitorParasiticide
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Malathion is a thiophosphate prodrug that is converted to active phosphate derivatives in animals and plants. These active metabolites inhibit acetylcholinesterase by binding covalently to its esteratic site, preventing the enzyme's rapid reactivation. This leads to an accumulation of acetylcholine, causing prolonged cholinergic effects.
Indications
Scabies (Sarcoptes scabiei)Head lice (pediculosis capitis) (for resistant cases)
Dosing
- Adult
- For scabies, apply twice, one week apart, to the whole body including scalp, neck, face, and ears, paying particular attention to webs of fingers/toes and under nails. Reapply to hands if washed. For hyperkeratotic scabies, 2-3 applications on consecutive days may be required. For head lice, apply 0.5% lotion, then reapply in 9-10 days.
Pharmacokinetics
Duration
Very long duration of action; phosphorylated enzyme reactivation half-life is in days.
Metabolism
Thiophosphate prodrug converted to active phosphate derivatives in animals and plants. Detoxification occurs via ester bonds in mammals and birds.
Excretion
Most organophosphates are excreted almost entirely as hydrolysis products in the urine.
Related guidelines
Other Cholinesterase Inhibitor drugs
Ask House about Malathion
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e, Katzung, BNF, Nelson·Verified: 2026-05-10 · House clinical team